IPO Pressure on an Equity Analyst
An equity research analyst covers Asian technology hardware. Her employer is joint bookrunner on the IPO of a chip-packaging company. During the roadshow, the head of investment banking asks her to publish an initiation report with a 'Buy' rating before the IPO prices, saying it will 'support the book.' Her draft model, built before the roadshow, supports 'Hold' with a fair value 8% below the top of the price range. Compliance has a written policy that initiation research is restricted until 40 days after pricing. The banker says the policy is 'guidance' and that the analyst's bonus is partly based on banking revenue. The analyst's direct supervisor is on leave. A salesperson has already told two clients to expect a 'positive initiation note.'
1. What should the analyst do when asked to publish a 'Buy' before the IPO prices?
Read the worked answer
The analyst should refuse to publish a 'Buy' and should not change the rating to support the book.
Reasoning:
- Her independent model supports Hold. Changing it because a banker asks is a research-integrity breach, not a judgement call about valuation.
- The 40-day restriction is a written compliance policy. A banker cannot downgrade it to 'guidance' because it is inconvenient.
- Her bonus link to banking revenue creates a conflict; that is a reason for more independence, not less.
- The salesperson's message to clients is already misleading and must be corrected.
She should:
- Tell the banker in writing that she will not publish before the restricted period and will not change the rating without new fundamental evidence.
- Escalate to the head of compliance or research supervisory backup because her direct supervisor is on leave.
- Preserve the draft model, emails and the banker's request.
- Ask compliance to correct the salesperson's client communication.
If she is pressured further, she should use the firm's whistleblowing or escalation channel rather than comply.
2. How should compliance respond to the banker's request and the salesperson's statement?
Read the worked answer
Compliance should treat this as a potential research-independence and marketing breach, not an internal scheduling dispute.
Actions:
- Confirm the 40-day restriction applies and instruct the banker to stop requesting pre-pricing initiation.
- Review emails, chat and calendar records for the request and any similar past pressure.
- Require the salesperson to send a correction to the two clients: no initiation note has been approved and no rating should be expected.
- Assess whether the banker's reference to the analyst's bonus was an attempt to influence research; escalate to the research oversight committee.
- Review whether the analyst's compensation structure needs a conflict review.
- Consider whether any client received material non-public information about the IPO book or the research plan.
Compliance should also protect the analyst from retaliation. The record should show who asked for what and what was refused.
3. What should happen if the banker escalates to senior management?
Read the worked answer
Senior management should uphold the restriction and the analyst's independence.
The escalation should be handled as follows:
- The research head, compliance and legal should meet the banker and state that the policy applies and the rating will not be changed to support the IPO.
- Any decision to waive the restriction would require a documented policy exception approved by compliance and disclosed under the firm's research rules; 'supporting the book' is not a valid basis.
- The analyst should not be removed from coverage or penalised for refusing. If coverage changes are proposed, they should be reviewed for retaliation.
- The salesperson's earlier message should be corrected and logged.
- The incident should go to the board or research oversight committee if senior management is involved in the pressure.
The underlying judgement is that IPO book-support pressure is exactly the conflict research independence rules exist to control. The analyst's Hold rating, based on her model, should be published after the restricted period with proper conflict disclosure.